Send feedback

C8A p.Arg444His

c.1331G>A · rs143908758 · VCV789429

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 9 submitters
AlphaMissense
likely benign
0.1731 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.393%, nfe)
Missense predictors
1/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
type I complement component 8 deficiency

Computational evidence

Protein change
AlphaMissense0.1731likely benign
REVEL0.861moderately pathogenic-leaning
SaProtLLR -5.50tolerated
⇒ REVEL calls this damaging; AlphaMissense and SaProt do not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 2.8GERP 0.57, phastCons 0.99
Regional constrainto/e 1.08unconstrained · MANE · 63 kb · p 0.034 · regional, not allelic
Overall
CADD24.3PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.393% European (non-Finnish) · 4,635/1,180,000 alleles
Filtering AF 0.383% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.379%
Overall 0.348% 5,625/1,614,134 alleles · rare
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.539% 186
European (non-Finnish)grpmax 0.393% 255
Remaining individualsnot grpmax-eligible 0.267% 374
South Asian 0.26% 384
Admixed American 0.22% 455
African / African-American 0.128% 782
Middle Eastern 0.099% 1,010
Ashkenazi Jewishnot grpmax-eligible 0.0236% 4,229

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
C8A
Protein
p.Arg444His
Coding
c.1331G>A
MANE Select
NM_000562
dbSNP
rs143908758
Type
single nucleotide variant
Location
chr1:56908064 (GRCh38)
Gene constraint
LOEUF 1.168 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 79.58 · 11 PDB
Residue 444
a UniProt-annotated variant site (in c8d1); the macpf domain; an α-helix
Full C8A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

type I complement component 8 deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Immunodeficiency due to a late component of complement deficiency (Orphanet):

Inheritance
Autosomal recessive

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/c8a-p-arg444his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown